Print Page     Close Window     

SEC Filings

AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document

Convertible Note Agreement | AC Immune SA, 11 December 20183/23

10.6. Entire Agreement 16
10.7. Severability 16
10.8. Waivers 16
10.9. Transfers or Assignments 16
10.10. Governing Law 16
10.11. Arbitration 16
10.12. Termination 16
Annexes 20





ABorrower is a Swiss stock corporation (société anonyme) registered under the registration number CHE-109.878.825. The Borrower has an issued share capital of CHF 1’347’253.80, divided into 67’362’690 registered shares, each with a nominal value of CHF 0.02 and fully paid-in (the “Shares”).


BThe Lender intends to support the continuation of the Borrower’s business activity by granting to the Borrower a convertible loan, subject to the terms and conditions of this Note Agreement.




If not defined otherwise in this Note Agreement, capitalized terms used in this Note Agreement shall have the meaning ascribed to them in Annex 1.


2.Convertible Loan




Subject to the terms and conditions of this Note Agreement, the Lender hereby makes a convertible loan (the “Loan”) to the Borrower in the amount of USD 50’000’000.00 (fifty million U.S. Dollars).


2.2.Lender Payment


The Lender shall fund the entire amount of the Loan within three Business Days following the License Agreement Effective Date (as defined below)(the occurrence of the payment, the “Closing” and the date of such occurrence, the “Closing Date”) to the following bank account:


Account holder: AC Immune SA, EPFL Innovation Park, Building B, CH-1015 Lausanne, Switzerland


Bank: Credit Suisse (Switzerland) Ltd. 

Address of Bank: Paradeplatz 8, 8001 Zurich, Switzerland 

Clearing: 4835



© AC Immune 2015